🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📯 Thrilled to share our latest article, now published in European Urology, summarizing current data and future perspectives on adjuvant therapy in renal cell carcinoma. Many thanks to my co-author Mathieu Larroquette, and Dr Gross-Goupil & Pr Ravaud for their mentorship! Here the link👇🏻

Adjuvant therapy in RCC : is the chapter of VEGF inhibitors definitively closed ? Check out our latest article, co-written with Florent Peyraud, Pr A.Ravaud and Dr M.Gross-Goupil in European Urology ⤵️ OncoAlert CHU de Bordeaux Université de Bordeaux sciencedirect.com/science/articl…

New Platinum Opinion from Florent Peyraud Mathieu Larroquette Alain Ravaud and Marine Gross-Goupil New Insights into Adjuvant Therapy in Renal Cell Carcinoma: Is the Chapter of VEGF Inhibitors Definitely Closed? buff.ly/3dvbEyE

Mais que veulent ces gens ?… que les professionnels de santé arrêtent de travailler, de soigner, de protéger ???

📯 Congrats for this collaborative work led by Antoine Italiano! Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression, opening new insights into IO! @BERGONIE33 Gustave Roussy nature.com/articles/s4301…

🔥The August issue Nature Cancer is out!🔥 Read about TLS and #immunotherapy in solid tumors, advances in #CART cell therapy, #TumorImmunology in prostate cancer, #chemotherapy and #leukemia relapse & more! Check the😍cover! Find the full issue 👇👇 go.nature.com/3DkdrT8

Le molnupiravir réduirait de 50% le risque d'hospitalisation ou décès merck.com/news/merck-and… Si c'est confirmé cela serait utile même si on peut avoir des craintes sur son activité mutagène Rappelons que le vaccin réduit de plus de 90% ce risque en toute sécurité Vaccinez vous

Combining chemotherapy with ICI in advanced solid tumours : rationale, efficacy and perspectives are discussed in our last review article published in EJC. Check it out! ⤵️ daste amaury Félix Lefort AmandineQuivy OncoAlert CHU de Bordeaux ejcancer.com/article/S0959-…

[MOVEMBER approche 📣] MERCI 🙏à Union Bordeaux Bègles qui réalisera des actions de sensibilisation samedi soir à l'occasion du match Union Bordeaux Bègles VS #Clermont et au Dr daste amaury, oncologue au CHU de Bordeaux qui fera le coup d'envoi fictif du match en soutien à Movember !🏉! A vos moustache👨

Clinical outcome measures in patients with soft-tissue #sarcomas are better following #anti-PD-1 treatment in a cohort prospectively selected for the presence of intratumoral tertiary lymphoid structures. C̲̲Z🔸 #NMEDClinical #immunotherapy nature.com/articles/s4159…

Ces images et l'impuissance qu'elles procurent sont un déchirement. Plus qu'un patrimoine, c'est la terre de toute ma jeunesse qui part en fumée. Pensées émues et soutien aux proches et à tous les habitants du #bassindarcachon. Merci aux #pompiers pour leur dévouement remarquable

Comme chaque mois de novembre c est l occasion de rappeler l importance des dépistage #cancer #prostate #testicule et de se faire de belle moustache !!!

Metastatic ccRCC : we discuss current treatment modalities, new approaches such as escalation/de-escalation strategies and innovative drugs in our last review article in Cancers MDPI mdpi.com/2072-6694/14/2… Félix Lefort CHU de Bordeaux OncoAlert

✨ Just out in Annals of Oncology! Our prospective study evaluating the impact of comprehensive molecular profiling of ctDNA in patients with advanced solid tumors. Gustave Roussy ESMO - Eur. Oncology doi.org/10.1016/j.anno…

Today our important study on air pollutants in the promotion of lung cancer has been published in nature led by Will Hill Emilia Lim Clare Weeden Swanton Lab ...Thread below🧵nature.com/articles/s4158…

The ESMO - Eur. Oncology LBAs are out And a wow for PEMBRO/EV (Presidential) OS 31.5 vs 16.1 months (HR 0.45) PFS 12.5 vs 6.3 months (HR 0.47) P<0.00001 A historic change for 1L mUC since Von Der Maase JCO 2000 Tom Powles #ESMO23 OncoAlert

👏Audrey Burban & Ahmad Sharanek for having conducted this work exploiting a metabolic vulnerability in GBM. Proud to be part of the story! Let's continue to work together for a better understanding of glioblastoma oncogenesis with CHU de Bordeaux @Thomas_Daubon Université de Bordeaux

Happy to have contributed to this collaborative work from GETUG about the characteristics of GI metastases in patients w. RCC : presentation, prognosis and ttt. Thank you Flo and cancel mathilde for conducting this study! @MarineGrossGoupil ejcancer.com/article/S0959-…

UK bowel cancer death rates forecast to rise by third among under-50s (Annals of Oncology ESMO - Eur. Oncology) theguardian.com/society/2024/j…

Une revue très exhaustive des cancers du poumon survenant chez les patients jamais fumeurs #LCINS ,Caracteristiques,Facteurs de risque et méthodes diagnostiques NatureRevClinOncol nature.com/articles/s4157…